United Kingdom guidelines

epic3: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. Journal of Hospital Infection 2014;86 Suppl 1:S1-70

• Webster J, Osborne S, Rickard CM, New K. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD007798. DOI: 10.1002/14651858.CD007798.pub3

• Shah PS, Shah N. Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005983. DOI: 10.1002/14651858.CD005983.pub2

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.  Rheumatology (Oxford) 2014;53(12):2306-9

• Fortin PM, Tejani AM, Bassett K, Musini VM. Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007057. DOI: 10.1002/14651858.CD007057.pub2   

USA guidelines

Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017;135(17):e927-e999

• Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, Roman K, Dua JS, Flynn I. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD004000. DOI: 10.1002/14651858.CD004000

• Baumer JH, Love S, Gupta A, Haines L, Maconochie IK, Dua JS. Salicylate for the treatment of Kawasaki disease in children. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD004175. DOI: 10.1002/14651858.CD004175.pub2

Other national and international guidelines

The Nephrology Association of Buenos Aires: Clinical Practice Guideline for ANCA-Associated Vasculitis With Renal Involvement. Medicina (B Aires) 2015;75 Suppl 1:1-38

• Fortin PM, Tejani AM, Bassett K, Musini VM. Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD007057. DOI: 10.1002/14651858.CD007057.pub3

Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version). Pediatrics International 2014;56(2):135-58       

• Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, Roman K, Dua JS, Flynn I. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD004000. DOI: 10.1002/14651858.CD004000

Health Policy Advisory Committee on Technology, Technology Brief May 2013: Replacement of peripheral venous catheters by clinical indications. http://www.health.qld.gov.au/healthpact/html/tech-briefs.asp    

• Webster J, Osborne S, Rickard C, Hall J. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database of Systematic Reviews 2010, Issue 3. Art. No.: CD007798. DOI: 10.1002/14651858.CD007798.pub2